These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6191160)

  • 1. [Insulin resistance caused by an increase in proteolytic enzyme activity at the site of insulin injection. Study in insulin-dependent diabetic subjects].
    Calle Pascual AL; Marañes Pallardó JP; Charro Salgado AL
    Med Clin (Barc); 1983 Apr; 80(12):524-6. PubMed ID: 6191160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Skin reaction following cutaneous insulin injection in diabetic patients requiring insulin].
    Heller H
    Allerg Asthma (Leipz); 1970; 16(4):161-7. PubMed ID: 4257714
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of aprotinin on insulin sensitivity in non-insulin-dependent diabetes mellitus.
    Laurenti O; Piccoli A; Bravi C; Cassone-Faldetta M; Bellini C; Leoni L; Ferri C; De Mattia G
    Diabet Med; 1996 Jul; 13(7):642-5. PubMed ID: 8840098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of the human skin bradykinin-destroying enzyme.
    Gecse A; Lonovics J; Zsilinszky E; Szekeres L
    J Med; 1971; 2(3):129-35. PubMed ID: 5002574
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes resistant to subcutaneous insulin: effect of aprotinin.
    N Engl J Med; 1981 Dec; 305(23):1413-4. PubMed ID: 6170889
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diabetes mellitus with excessive insulin requirement].
    Berglund S
    Lakartidningen; 1968 Apr; 65(14):1400-4. PubMed ID: 5742584
    [No Abstract]   [Full Text] [Related]  

  • 7. Parathyroid hypertensive factor and non-insulin-dependent diabetes mellitus.
    Ho MS; Lewanczuk RZ; Teh BH; Lee SC; Pang PK
    J Cardiovasc Pharmacol; 1994; 23 Suppl 2():S31-4. PubMed ID: 7518543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance against subcutaneous insulin successfully managed with aprotinin.
    Müller WA; Taillens C; Léreret S; Berger M; Philippe J; Halban PA; Offord RE
    Lancet; 1980 Jun; 1(8180):1245-6. PubMed ID: 6155578
    [No Abstract]   [Full Text] [Related]  

  • 9. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus.
    Maddux BA; Sbraccia P; Kumakura S; Sasson S; Youngren J; Fisher A; Spencer S; Grupe A; Henzel W; Stewart TA
    Nature; 1995 Feb; 373(6513):448-51. PubMed ID: 7830796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous aprotinin causes local hyperaemia. A possible mechanism by which aprotinin improves control in some diabetic patients.
    Williams G; Pickup JC; Bowcock S; Cooke E; Keen H
    Diabetologia; 1983 Feb; 24(2):91-4. PubMed ID: 6188643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A defect in cell-mediated immune function in insulin-resistant diabetic and obese subjects.
    Kolterman OG; Olefsky JM; Kurahara C; Taylor K
    J Lab Clin Med; 1980 Sep; 96(3):535-43. PubMed ID: 6995542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistance to insulin, brittle abetes and reaction of the fasininsulin activity during the administration of biguanides].
    Klein W; Hole P; Dietzmann HB; Buding A
    Munch Med Wochenschr; 1969 Sep; 111(38):1908-12. PubMed ID: 5394856
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus.
    González-Clemente JM; Mauricio D; Richart C; Broch M; Caixàs A; Megia A; Giménez-Palop O; Simón I; Martínez-Riquelme A; Giménez-Pérez G; Vendrell J
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):525-9. PubMed ID: 16268804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reference value and cut-off value for diagnosis of insulin resistance in type 2 diabetes mellitus].
    Kuwana B; Urayama O; Kawai K
    Rinsho Byori; 2002 Apr; 50(4):398-403. PubMed ID: 12014020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistant diabetes mellitus.
    Zhu XX; Wang ZG; Qiu CL; Zhong XL
    Chin Med J (Engl); 1980 Nov; 93(11):737-44. PubMed ID: 6775883
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the sensitivity of adipose tissue to insulin during the treatment of diabetic patients].
    Iaroshevskiĭ IuA
    Sov Med; 1981; (11):38-40. PubMed ID: 7038897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.